Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology)

AIM OF THE STUDY: Systemic chemotherapy for patients with pancreatic cancer has limited impact on overall survival (OS). Patients eligible for chemotherapy should be selected carefully. The aim of the study was to search for prognostic factors for survival in patients with gemcitabine (Gem)-refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: İnal, Ali, Kos, F. Tuba, Algın, Efnan, Yıldız, Ramazan, Berk, Veli, Unek, İlkay T., Colak, Dilsen, Dane, Faysal, Geredeli, Caglayan, Isıkdogan, Abdurrahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444440/
https://www.ncbi.nlm.nih.gov/pubmed/26034390
http://dx.doi.org/10.5114/wo.2014.43933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444440/
https://www.ncbi.nlm.nih.gov/pubmed/26034390
http://dx.doi.org/10.5114/wo.2014.43933

Ejemplares similares